Top Markets
#1 Status Status +18.91%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +18.45%
#4 Wrapped NXM Wrapped NXM +15.13%
#5 Ontology Gas Ontology Gas +11.65%
#6 DMT-NAT DMT-NAT +8.98%
#7 Pons Pons +8.13%
#8 Provenance Blockchain Provenance Blockchain +7.18%
#9 Nesa Nesa +7.18%
#10 Janction Janction +7.01%
Coin of the day
Status Status
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Classificação em ações #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Preço da ação
$0.1502
Última sincronização: 2024-11-04
Valor de mercado
$6.43M
Variação (1 dia)
-5.45%
Variação (1 ano)
0.00%
País
US
Negociar Renalytix Plc (RNLX)

Categoria

Healthcare
Rácio P/S de Renalytix Plc (RNLX)
Rácio P/S em August 2026 TTM: 9.85
De acordo com os relatórios financeiros mais recentes e o preço das ações da Renalytix Plc, o rácio P/S atual (TTM) é 9.85. No final de 2023, o rácio P/S era 35.27.
Histórico do rácio P/S da Renalytix Plc de 2018 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 9.85 66.11%
2024 5.93 -83.19%
2023 35.27 25.79%
2022 28.04 -96.18%
2021 733.39 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
1.64 -83.31%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
77.67 688.51%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
0.84 -91.45%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
6.37 -35.29%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
- -
US